INTERNATIONAL CONGRESS OF
CancerGenetics
برنامه سخنرانی ها
Gene Editing in Cancer Panel
2026/10/23
The role of the microbiome in cancer Panel
2026/10/23
Carcinogenic Viruses Panel
2026/10/24
Regenerative Medicine in Cancer Treatment Panel Panel
2026/10/24
Epigenetics and Cancer Panel Panel
2026/10/24
Polymorphisms and Metabolic Interactions in Cancer Panel
2026/10/25
Personalized medicine in cancer Panel
2026/10/25
Bioinformatics in Cancer Panel Panel
2026/10/25
Oral presentations
A Practical Framework for Modeling and Engineering the Bone Marrow Tumor Microenvironment, Focusing on Key Parameters and Therapeutic Applications
Panel:
Circular RNAs in Hepatocellular Carcinoma: Molecular Mechanisms, Tumor Microenvironment, Therapeutic Resistance, and Clinical Potential
Panel: Regenerative Medicine in Cancer Treatment Panel
Cross-Cohort Transcriptomic Meta-Analysis Identifies GAB1 as a Reproducible Signal of Platinum Resistance in High-Grade Serous Ovarian Cancer
Panel: Drug Resistance and Novel Therapeutic Targets
Electro-Ionic Tumor Microenvironment as a Design Cue for Engineering Smart Drug Delivery Systems
Panel:
Epstein–Barr Virus-Encoded MicroRNAs in Gastric Cancer: Linking Viral Epigenetic Regulation to Tumor Progression and Clinical Outcome
Panel: Carcinogenic Viruses
Integrated Multi-Cohort Transcriptomic Analysis Identifies BST2 as a Candidate Immune-Associated Biomarker in Non-Small cell lung cancer
Panel: Tumor Immunology and Cancer Immunotherapy
Lactate-Mediated Mechanisms of Cancer Therapy Resistance
Panel: Regenerative Medicine in Cancer Treatment Panel
Mesenchymal Stem Cell-Derived Exosomal Non-Coding RNAs as Suppressors of Hepatocellular Carcinoma Progression
Panel: Regenerative Medicine in Cancer Treatment Panel
Metabolic–Epigenetic Crosstalk in Human Disease: How Metabolites Control Gene Expression and Cellular Function
Panel: Personalized medicine in cancer
Pancreatic Cancer and DNA Damage Repair Deficiency: Mechanisms, Biomarkers, and Therapeutic Implications
Panel: Personalized medicine in cancer
Processed Pseudogene Dysregulation in Testicular Germ Cell Tumors Reveals High-Contrast Molecular Candidates
Panel: Bioinformatics in Cancer Panel
Revisiting the Warburg Effect: Metabolic Plasticity, Lactate Signaling, and Therapeutic Opportunities in Cancer
Panel: Polymorphisms and Metabolic Interactions in Cancer
Role of CRISPR/Cas9 Gene Editing in Targeting CXCR4, CD133 and EpCAM to Inhibit Cell Adhesion and Metastasis in Colorectal Cancer
Panel: Regenerative Medicine in Cancer Treatment Panel
Roles of Sirtuin-1 in Lung Cancer: From Tumor Progression to Targeted Therapy
Panel: Drug Resistance and Novel Therapeutic Targets
The Mitochondrial Transfer Paradox: A Comparative Transcriptomic and Connectivity Map Profiling of Divergent Fates in Tumor and Immune Cells
Panel: Bioinformatics in Cancer Panel
Torque Teno Virus Coinfection with High-Risk Human Papillomavirus in Cervical Cancer-Related Samples:
Panel: Carcinogenic Viruses
Tumor-Suppressor Checkpoints in Partial Reprogramming: Balancing Epigenetic Rejuvenation, Lineage Fidelity, and Oncogenic Risk
Panel: Epigenetics and Cancer Panel
Poster presentations
A Practical Framework for Modeling and Engineering the Bone Marrow Tumor Microenvironment, Focusing on Key Parameters and Therapeutic Applications
Panel: Epigenetics and Cancer Panel
A Review of Gene therapy in cancer
Panel: Epigenetics and Cancer Panel
Adenoviral Vector-Mediated Monoclonal Antibody Gene Delivery in Cancer Immunotherapy: Opportunities and Challenges
Panel: Epigenetics and Cancer Panel
An update on application of niosomes for delivering miRNA, siRNA, and anticancer drugs: A review
Panel: Epigenetics and Cancer Panel
Artificial Intelligence and Bioinformatics in Cancer: From Multi-Omics Integration to Precision Immunotherapy
Panel: Epigenetics and Cancer Panel
Cationic Liposome-Encapsulated Adenoviruses: Overcoming CAR-Dependent Resistance & Systemic Antitumor Immunity
Panel: Epigenetics and Cancer Panel
cfDNA Methylation in Liquid Biopsy: Current Perspectives and Future Directions for Early Cancer Detection
Panel: Epigenetics and Cancer Panel
Challenges and Emerging Strategies of CAR-T Cell Therapy in Solid Tumors: A Narrative Review
Panel: Epigenetics and Cancer Panel
Circular RNAs in Hepatocellular Carcinoma: Molecular Mechanisms, Tumor Microenvironment, Therapeutic Resistance, and Clinical Potential
Panel: Epigenetics and Cancer Panel
Circulating piRNAs in Colorectal Cancer: From Biomarker Discovery to Clinical Monitoring
Panel: Epigenetics and Cancer Panel
CRISPR-Engineered Akkermansia muciniphila Synergizes with Intratumoral Microbiome Remodeling to Overcome Immunotherapy Resistance in KRAS-Mutant Colorectal Cancer
Panel: Epigenetics and Cancer Panel
Cross-Cohort Transcriptomic Meta-Analysis Identifies GAB1 as a Reproducible Signal of Platinum Resistance in High-Grade Serous Ovarian Cancer
Panel: Epigenetics and Cancer Panel
Deciphering Tumor Molecular Heterogeneity in the Era of Precision Medicine.
Panel: Epigenetics and Cancer Panel
Decoupling Cellular Rejuvenation from Oncogenic Plasticity: A Single-Cell and Multi-Omic Framework for Identity-Preserving Partial Reprogramming
Panel: Epigenetics and Cancer Panel
Development and Immunological Application of Bispecific Antibodies in the Treatment of Gastric Cancer
Panel: Epigenetics and Cancer Panel
Differential expression of LncRNA ITPK1-AS1 gene expression in gastric cancer
Panel: Epigenetics and Cancer Panel
Effects of Sialic Acid and Temozolomide on GFAP Gene Expression in the 1321N1 Glioma Cell Line
Panel: Epigenetics and Cancer Panel
Electro-Ionic Tumor Microenvironment as a Design Cue for Engineering Smart Drug Delivery Systems
Panel: Epigenetics and Cancer Panel
EMERGING MOLECULAR TARGETS AND MECHANISMS OF DRUG RESISTANCE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: TOWARD PERSONALIZED OPHTHALMIC THERAPY
Panel: Epigenetics and Cancer Panel
Engineering Bacterial cellulose for Cancer Drug Delivery: From Controlled Release to Therapeutic Applications
Panel: Epigenetics and Cancer Panel
Epigenetic and Metabolic Networks Shaping CAR-T Cell Exhaustion and Memory
Panel: Epigenetics and Cancer Panel
Epigenetic Footprints of Cancer in Cell-Free DNA and Their Applications in Early Cancer Detection
Panel: Epigenetics and Cancer Panel
Evaluation of the Therapeutic Potential of a Bifidobacterium longum-Derived Postbiotic in Skin Cancer: Concurrent Assessment of Anticancer and Antioxidant Activities
Panel: Epigenetics and Cancer Panel
Extrachromosomal DNA (ecDNA)-Associated Transcription–Replication Conflicts in Cancer: Mechanisms, Synthetic Lethal Vulnerabilities, and Emerging Personalized Therapeutic Strategies
Panel: Epigenetics and Cancer Panel
Extrachromosomal DNA Heterogeneity in Dedifferentiated Liposarcoma: Linking Therapeutic Adaptation and Tumor Immune Evasion: A Narrative Review
Panel: Epigenetics and Cancer Panel
From Clonal Evolution to Relapse: Genomic and Epigenetic Drivers of Treatment Resistance in Pediatric B-Cell Acute Lymphoblastic Leukemia — A Systematic Review
Panel: Epigenetics and Cancer Panel
From L-Asparaginase Engineering to Precision Medicine: The Role of ASNS in Leukemic Cell Sensitivity
Panel: Epigenetics and Cancer Panel
From Viral Detection to Oncogenic Evidence: A Targeted Scoping Review of Thresholds, Contamination Control, Validation, and Causality Assessment in Human Tumor Sequencing Studies
Panel: Epigenetics and Cancer Panel
Fusobacterium nucleatum in Colorectal Cancer: Molecular Crosstalk Between Microbial Virulence and Host Oncogenic Signaling
Panel: Epigenetics and Cancer Panel
Genomic Alterations and Their Role in the Management of Uterine Carcinosarcoma: Focus on TP53 and Biomarker-Guided Therapy
Panel: Epigenetics and Cancer Panel
Genomic Alterations in Cancer: Implications for Precision Diagnosis and Targeted Therapy
Panel: Epigenetics and Cancer Panel
Gut Microbiome and Colorectal Cancer: Molecular Mechanisms, Biomarkers, and Therapeutic Opportunities
Panel: Epigenetics and Cancer Panel
Gut Microbiome–Neural Crosstalk in Cancer: Emerging Implications for Perineural Invasion and Metastatic Progression
Panel: Epigenetics and Cancer Panel
How Germline DNA-Repair Variants May Influence the Intratumoral Microbiome in Breast Cancer: An Emerging Mechanistic Hypothesis
Panel: Epigenetics and Cancer Panel
Human Milk miRNAs and Cancer: From Early-Life Molecular Programming to Cancer Risk
Panel: Epigenetics and Cancer Panel
Identification of Candidate Drugs for Breast Cancer via Transcriptomic Signature Matching Using Connectivity Map
Panel: Epigenetics and Cancer Panel
Identification of Hub Genes Associated with Tamoxifen Treatment in Recurrent Breast Cancer: An Integrated Bioinformatics Analysis
Panel: Epigenetics and Cancer Panel
Immune Checkpoints Dysregulation in Precancerous Colorectal Polyps
Panel: Epigenetics and Cancer Panel
Immunotherapy for Cervical Cancer: Mechanistic Insights, Clinical Challenges, and Synergistic Combination Paradigms
Panel: Epigenetics and Cancer Panel
In Silico Transcriptomic Analysis of Radiation-Induced Bystander Effects in Human Fibroblasts: Uncovering Key Regulatory Networks and Ribosome Biogenesis
Panel: Epigenetics and Cancer Panel
Integrated Multi-Cohort Transcriptomic Analysis Identifies BST2 as a Candidate Immune-Associated Biomarker in Non-Small cell lung cancer
Panel: Epigenetics and Cancer Panel
Interferon-Related Hub Genes in Resistant Breast Cancer CAFs
Panel: Epigenetics and Cancer Panel
Interpreting Colibactin-Associated Mutational Signatures and pks⁺ Bacterial Detection in Colorectal Cancer: Temporal Discordance and Biomarker Limitations
Panel: Epigenetics and Cancer Panel
Introduction of AOX1 gene as an effective gene in tumorigenesis in thyroid papillary carcinoma
Panel: Epigenetics and Cancer Panel
Investigating the Effects of miR-204-Enriched Mesenchymal Stem Cell-Derived Exosomes on TGF-β1-Induced EMT in 4T1 Breast Cancer Cells
Panel: Epigenetics and Cancer Panel
Lack of Correlation Between the CCR5-D32 Mutation and Acute Myeloid Leukemia in Iranian Patients
Panel: Epigenetics and Cancer Panel
Lactate-Mediated Mechanisms of Cancer Therapy Resistance
Panel: Epigenetics and Cancer Panel
Low-Allele-Fraction Pathogenic/Likely Pathogenic Calls in Diagnostic Whole-Exome Sequencing for Hereditary Breast Cancer: A Cautionary Case Series of Sanger Discordance
Panel: Epigenetics and Cancer Panel
Mechanistic Insights into Long Non-coding RNA-Mediated Gene Regulation Across Human Diseases
Panel: Epigenetics and Cancer Panel
Mesenchymal stem cell derived exosomes as a potential carrier of non-coding RNA in cancer therapy
Panel: Epigenetics and Cancer Panel
Mesenchymal Stem Cell-Derived Exosomal Non-Coding RNAs as Suppressors of Hepatocellular Carcinoma Progression
Panel: Epigenetics and Cancer Panel
Metabolic–Epigenetic Crosstalk in Human Disease: How Metabolites Control Gene Expression and Cellular Function
Panel: Epigenetics and Cancer Panel
miRNA-Mediated Regulation of the NRF2/KEAP1 Pathway in Glioblastoma
Panel: Epigenetics and Cancer Panel
Mitomycin and zinc oxide nanoparticle effect on p53 and endothelial growth factor VEGF genes expression in MCF-7 Breast cancer cell line
Panel: Epigenetics and Cancer Panel
Multi-Center Platform for Cancer Detection from Histopathology Images Using Federated Learning
Panel: Epigenetics and Cancer Panel
Natural Seed Informed and Structure Aware Computational Design of Artificial miRNA Seed Regions Targeting the KRAS 3′UTR
Panel: Epigenetics and Cancer Panel
Neuro-Cancer Crosstalk in the Tumor Immune Microenvironment: Molecular Mechanisms of Immune Evasion and Tumor-Promoting Inflammation
Panel: Epigenetics and Cancer Panel
Optimizing Tumor-Stromal Exosome Dose for Enhanced Proliferation in MDA-MB-231 Breast Cancer Cells
Panel: Epigenetics and Cancer Panel
Pancreatic Cancer and DNA Damage Repair Deficiency: Mechanisms, Biomarkers, and Therapeutic Implications
Panel: Epigenetics and Cancer Panel
Patient-Derived Thyroid Cancer Organoids for Precision Medicine: Preclinical Applications and Emerging Clinical Potential
Panel: Epigenetics and Cancer Panel
Plant-Derived Berberine and Artesunate as Emerging Therapeutic Candidates Against Human Herpesvirus 8-Driven Kaposi Sarcoma: Molecular Mechanisms and Translational Perspectives
Panel: Epigenetics and Cancer Panel
Precision Genome Editing in Oncology through Base and Prime Editing: Molecular Foundations, Genomic Fidelity, and Therapeutic Prospects
Panel: Epigenetics and Cancer Panel
Precision Medicine in Oncology: Molecular Biomarkers and Genomic Strategies for Personalized Cancer Therapy
Panel: Epigenetics and Cancer Panel
Preliminary Assessment of the Effects of Chicory-Derived Inulin on the Viability of Human Renal Carcinoma ACHN Cells
Panel: Epigenetics and Cancer Panel
Processed Pseudogene Dysregulation in Testicular Germ Cell Tumors Reveals High-Contrast Molecular Candidates
Panel: Epigenetics and Cancer Panel
Proteogenomic Divergence Between mRNA Abundance and Protein Output in Cancer: Implications for Kinase-Centric Pathway Modeling
Panel: Epigenetics and Cancer Panel
Recombinant oncolytic adenoviruses encoding PD-L1 inhibitors: a novel approach to cancer immunotherapy
Panel: Epigenetics and Cancer Panel
Revisiting the Warburg Effect: Metabolic Plasticity, Lactate Signaling, and Therapeutic Opportunities in Cancer
Panel: Epigenetics and Cancer Panel
Role of CRISPR/Cas9 Gene Editing in Targeting CXCR4, CD133 and EpCAM to Inhibit Cell Adhesion and Metastasis in Colorectal Cancer
Panel: Epigenetics and Cancer Panel
Roles of Sirtuin-1 in Lung Cancer: From Tumor Progression to Targeted Therapy
Panel: Epigenetics and Cancer Panel
scRNA-seq-Derived Transcriptional State Trajectories in EGFR-Mutant Lung Adenocarcinoma: A Critical Review of Therapy-Induced Convergence toward a Slow-Cycling Persister Phenotype
Panel: Epigenetics and Cancer Panel
Selective Prevention of Immune Checkpoint Inhibitor–Induced Hypophysitis Without Compromising Antitumor Immunity
Panel: Epigenetics and Cancer Panel
Sialic Acid Attenuates Temozolomide-Induced Apoptosis in 1321N1 Glioma Cells via Downregulation of BAX Expression
Panel: Epigenetics and Cancer Panel
Spatial Transcriptomic Signatures of ICI Resistance in Solid Tumors: Cellular Niches, Cell–Cell Interactions, and Computational Biomarkers
Panel: Epigenetics and Cancer Panel
Targeted siRNA delivery in cervical cancer using liposomal nanoparticles
Panel: Epigenetics and Cancer Panel
Targeting Epstein–Barr Virus-Induced Oncogenic Pathways Using Natural Polyphenols: Therapeutic Potential of EGCG and Resveratrol
Panel: Epigenetics and Cancer Panel
Targeting Metabolic Vulnerabilities in Cancer: From the Warburg Effect to Antiparasitic Drug Repurposing
Panel: Epigenetics and Cancer Panel
Targeting the SLC7A11/GSH/GPX4 Axis in Cancer: From Redox Homeostasis to Therapeutic Vulnerability
Panel: Epigenetics and Cancer Panel
The Association Between the Gut Microbiome and Cancer Treatment: From Modulation of Therapeutic Response to Microbial Interventions
Panel: Epigenetics and Cancer Panel
The Gut Microbiome as a Predictor of Immune Checkpoint Inhibitor Efficacy and Immune-Related Toxicity: A Translational Evidence Gap Analysis
Panel: Epigenetics and Cancer Panel
The Intratumoral Microbiome in Cancer: Molecular Mechanisms and Therapeutic Perspectives
Panel: Epigenetics and Cancer Panel
The Mitochondrial Transfer Paradox: A Comparative Transcriptomic and Connectivity Map Profiling of Divergent Fates in Tumor and Immune Cells
Panel: Epigenetics and Cancer Panel
The Nurse's Role in Translating Genomic Findings into Person-Centered Palliative Care Plans for Cancer Patients: A Scoping Review
Panel: Epigenetics and Cancer Panel
The Role of Covert Germline Predisposition and Polygenic Susceptibility in Pediatric Acute Lymphoblastic Leukemia and Their Clinical Implications
Panel: Epigenetics and Cancer Panel
The Role of Gut Microbiome in Cancer: From Dysbiosis to Non‑Invasive Biomarkers
Panel: Epigenetics and Cancer Panel
The Role of the Gut Microbiome and Microbial Metabolites in Modulating Responses to Immune Checkpoint Inhibitors (ICIs): A Review of Immunological Mechanisms, Clinical Evidence and Microbiome-Based Therapeutic Strategies
Panel: Epigenetics and Cancer Panel
The stress-microbiome-cancer triad and the impact of catecholamines on Host-Microbe Interactions and tumor progression
Panel: Epigenetics and Cancer Panel
TLR3 Genetic Variation in Virus-Related Hepatocellular Carcinoma
Panel: Epigenetics and Cancer Panel
Transcriptome-Derived Immune Activity in Breast Cancer Reveals Prognostic CCL19–IL10 Expression States with External Evaluation in SCAN-B
Panel: Epigenetics and Cancer Panel
Transcriptome-Driven Repurposing of Approved Drugs for Cervical Cancer: A Connectivity Map Approach
Panel: Epigenetics and Cancer Panel
Transcriptome-Driven Repurposing of Approved Drugs for Pancreatic Ductal Adenocarcinoma: A Connectivity Map Approach
Panel: Epigenetics and Cancer Panel
Transcriptomic and PPI Network Analysis Reveals Hub Genes in Breast Cancer-Associated Fibroblasts
Panel: Epigenetics and Cancer Panel
Tumor-Suppressor Checkpoints in Partial Reprogramming: Balancing Epigenetic Rejuvenation, Lineage Fidelity, and Oncogenic Risk
Panel: Epigenetics and Cancer Panel
Unraveling the Cellular and Spatial Heterogeneity of Ocular Cancers through Single-Cell and Spatial Omics
Panel: Epigenetics and Cancer Panel
When Bacterial Redox Meets Tumor Metabolism: Decoding the Enterococcus faecalis–Cancer Crosstalk
Panel: Epigenetics and Cancer Panel
